Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SmartBreast
Pittsburgh, Pennsylvania, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
SmartBreast's molecular breast imaging devices, especially the EVE CLEAR SCAN series, show a marked increase in early breast cancer detection rates for women with dense breast tissue (up to 12 per 1,000 vs. 3.2 per 1,000 for mammography alone), as demonstrated in clinical studies with thousands of patients[1][2][5][6].
- Therapeutic areas
- Oncology
- Modalities
- DeviceAI softwareClinical decision support software
- Industry
- Medical Imaging
02
Partnerships
FoxSemicon Integrated Technologies, Inc. (FITI) – manufacturing partner[6]GE Healthcare (MBI technology and CZT detectors supplier)[1][4][5][6]Dilon Technologies (previous MBI assets)[4][6]
Beyond the preview
Go deeper on SmartBreast.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SmartBreast.